Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Ono claims iNOS inhibitors

April 16, 1998

Progenitor discovers first protein lipase gene expressed in endothelial tissue

April 16, 1998

TP10 improves outcome in open heart surgery model

April 15, 1998

Novel ECE inhibitor isolated from Streptomyces

April 14, 1998

Carter-Wallace discontinues sepsis study

April 14, 1998

Attenuation of septic insult with a combination of ibuprofen, cimetidine and diphenhydramine

April 14, 1998

TNFR:Fc evaluated clinically for congestive heart failure

April 9, 1998

Leukocyte activation inhibitor active in animal models of myocardial infarction

April 6, 1998

Green Cross reveals potent, selective angiotensin II antagonists

April 6, 1998

Positive results obtained with apoptosis suppressant in heart attack

April 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...